Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IndyGeneUS AI is building the world's largest blockchain-encrypted genomics and clinical data repository for indigenous and diaspora African populations, enabling genomics-driven target identification, precision drug discovery, and bioanalytics to address global health inequities. They develop next-generation sequencing approaches, and demonstrated application in rare disease gene panels and mental health gene expression assays; no marketed or late-stage clinical therapeutics reported as of 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IndyGeneUS AI.